Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
53.83
-0.03 (-0.06%)
Aug 1, 2025, 4:00 PM - Market closed
Protagonist Therapeutics Employees
Protagonist Therapeutics had 126 employees as of December 31, 2024. The number of employees increased by 14 or 12.50% compared to the previous year.
Employees
126
Change (1Y)
14
Growth (1Y)
12.50%
Revenue / Employee
$1,649,214
Profits / Employee
$445,976
Market Cap
3.34B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 126 | 14 | 12.50% |
Dec 31, 2023 | 112 | 7 | 6.67% |
Dec 31, 2022 | 105 | -13 | -11.02% |
Dec 31, 2021 | 118 | 39 | 49.37% |
Dec 31, 2020 | 79 | 6 | 8.22% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PTGX News
- 5 weeks ago - Protagonist Therapeutics to Host Conference Call to Announce an Oral Obesity Development Candidate - Accesswire
- 6 weeks ago - Protagonist Therapeutics: Two 'Slam Dunk' Sets Of Pivotal Data Set Up Bull Case - Seeking Alpha
- 2 months ago - Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera - Business Wire
- 2 months ago - Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025 - Accesswire
- 3 months ago - Protagonist Reports First Quarter 2025 Financial Results and Provides Corporate Update - Accesswire
- 3 months ago - Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025 - Accesswire
- 3 months ago - Protagonist Therapeutics Reports Granting of Inducement Award - Accesswire
- 4 months ago - Protagonist Therapeutics Named to Fast Company's Annual List of the World's Most Innovative Companies of 2025 - Accesswire